Finance

Lists
Q1 2027 earnings • released • Revenue beat +5.29%
See results
7733:TYO
Olympus Corp
¥1,906.00
+1.82%
(+34.00) 1D
Aug 7, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 7733...
Open
¥1,861
High
¥1,920
Low
¥1,843
Mkt. cap
2.12T
Avg. vol.
3.97M
Volume
6.11M
P/E ratio
31.08
52-wk high
¥2,168
52-wk low
¥1,302
EPS
¥61
Shares outstanding
341.42M
No. of employees
28K
Open
¥1,861
High
¥1,920
Low
¥1,843
Mkt. cap
2.12T
Avg. vol.
3.97M
Volume
6.11M
P/E ratio
31.08
52-wk high
¥2,168
52-wk low
¥1,302
EPS
¥61
Shares outstanding
341.42M
No. of employees
28K
News stories
From sources across the web
Profile
Olympus Corporation is a Japanese manufacturer of optics and reprography products, headquartered in Hachioji, Tokyo. Olympus was founded on October 12, 1919 as Takachiho Seisakusho by Takeshi Yamashita, initially specializing in microscopes and thermometers, and later in imaging. In 1921, the name Olympus was registered as a trademark. In 1942, the company was renamed Takachiho Optical Industries, and in 1949 it was renamed Olympus Optical Co., Ltd. In 2003, the company adopted its current name, Olympus Corporation. Olympus holds roughly a 70 percent share of the global endoscope market, estimated to be worth approximately US$2.5 billion. As of 2025, endoscopes and related surgical technologies are now Olympus's exclusive product line. It was formerly also a maker of cameras, camera lenses and dictaphones, until it divested this part to OM Digital Solutions in 2020. It divested from its microscopy and scientific imaging division in 2023, selling it to Bain Capital for approximately $3.1 billion; the division operates as Evident Corporation. Wikipedia
About Olympus Corp
CEOYasuo Takeuchi
Employees28.1K
FoundedOct 12, 1919
Headquarters-
SectorMedical device
Websiteolympus.co.jp
Last report
Aug 7, 2026
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
240.40B / 228.33B
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
247.84B
261.04B
295.28B
240.40B
Cost of goods sold
86.54B
96.15B
102.52B
-
Cost of revenue
86.54B
96.15B
102.52B
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
119.90B
125.65B
104.14B
-
Operating expense
127.74B
140.86B
145.88B
-
Total operating expenses
214.27B
237.01B
248.41B
-
Operating income
33.56B
24.04B
46.88B
-
Other non operating income
-
-
-819.00M
-
EBT including unusual items
27.90B
22.13B
27.08B
-
EBT excluding unusual items
27.90B
22.13B
47.09B
-
Income tax expense
7.70B
7.96B
2.26B
-
Effective tax rate
27.61%
35.98%
8.36%
-
Other operating expenses
7.83B
15.21B
6.54B
-
Net income
20.20B
14.17B
24.82B
-
Net profit margin
8.15%
5.43%
8.40%
-
Earnings per share
-
-
-
-
Interest and investment income
3.64B
356.00M
3.96B
-
Interest expense
-5.28B
-2.34B
-2.92B
-
Net interest expenses
-1.64B
-1.99B
1.04B
-
Depreciation and amortization charges
-
-
35.20B
-
EBITDA
50.30B
41.76B
63.42B
-
Gain or loss from assets sale
-
-
12.08B
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps